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Molecular dockingAbstract Pergularia daemia (Forsk.) chiov., is a milk weed of Asclepiadaceae family. In the present
study b-sitosterol, b-amyrin, a-amyrin and lupeol were identiﬁed in the leaf by GC–MS. Molecular
docking studies were performed to evaluate their activities on phospholipase A2 (PLA2) and
L-amino acid oxidase enzymes which constituted a rich source in snake venoms (Naja naja). Snake
venom Phospholipase A2 with PDB code 1A3D devoid of co-crystallized ligand was extracted from
Protein Data Bank. Using Molegro Virtual Docker two cavities are formed by cocrystallization.
L-Amino acid oxidase (PDB code 4E0V) was a receptor model with a co-crystallized ligand
FAD. Among the phytochemicals analysed, b-sitosterol displayed high afﬁnity of binding to the
active site regions of phospholipase A2 and L-amino acid oxidase, respectively. The afﬁnity of bind-
ing was 125.939 and 157.521 kcal/mole identiﬁed by gold scores. a-Amyrin and b-amyrin had
two hydrogen bond interactions with PLA2. Hence this study suggests that b-sitosterol identiﬁed
in P. daemia can antagonize PLA2 and LAAO activities and forms a theoretical basis for the folk
use of the plant against snake venom.
 2015 Production and hosting by Elsevier B.V. on behalf of Academy of Scientific Research &
Technology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Pergularia daemia is also called as Yugmaphala a perennial,
small, twining herb with major pharmacological activities
being reported on different parts of the plant. Arial shootsare known to possess anti-emetic and expectorant properties
[1]. Singh et al. reported the probable use of plant parts as
anti-asthmatic, rheumatic swellings and anti snake venin [2].
The plant also acts as an Anthelmintic and antiseptic [3–5].
Dried leaves are Anti rheumatic, anti bronchitic, have wound
healing properties, reduce body pains, infantile diarrhoea,
amenorrhoea and dysmenorrhoea [1,6–8]. Fresh root is used
as abortifacient and can treat gonorrhoea [10]. Shoots treat
whooping cough [9,11], stem bark acts against malaria, and
twig as an antipyretic and appetizer [12,13]. Moreover,
Aqueous, ethanolic and petroleum ether extracts of P. daemia
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antibacterial properties [14,15]. Phytochemicals like glucosides
and cardenolides (calotoxin, calotropagenin, dihy-
drocalotropagenin, calotropin, uscharidin) in seed, coroglauci-
genin, corotoxigenin, uscharidin and uzarigenin in stem are
identiﬁed [16]. Roots were reported to contain b-sitosterol,
lupeol, lupeol acetate, a, b-amyrin and its acetate [17–19].
Apart from this, Jalalpure et al. reported leupol-3-b-
transcrotonate along with the acetate of a-amyrin, b-amyrin,
oleanolic acid and b-sitosterol from the hexane extract of
whole plant [15]. Organic esters, fatty acids and phenolic com-
pounds were identiﬁed by GC MS analysis of the ethanolic
extract of the plant [20].
Though the literature shows the folk use of the plant to
treat snake bite, there exists no theoretical evidence. The pre-
sent work, reports the isolation and structural elucidation of
b-sitosterol, b-amyrin, a-amyrin and lupeol simultaneously
from the leaf powder of P. daemia using GC–MS for the ﬁrst
time. Further computer-aided analysis was initiated to evalu-
ate the activity of these compounds against snake bite after
their in vitro studies thus aiming at developing a theoretical
evidence for folk use of the plant.
2. Material and methods
2.1. General experimental procedure
All the chemicals in the study were purchased from Sigma and
Merck Pvt. Ltd and are used without further puriﬁcation. The
venom was purchased from Calcutta Snake Park, Calcutta,
India, in its pure form. GC–MS, column, protein data, docking
was performed in Ohmlina Centre for Molecular Research,
India.Thewhole plant ofP. daemia (Forsk) chiov.,was collected
in the month of August, 2010, from Krishna district, India. The
sample was identiﬁed using trnL-trnF intergenic spacer
sequence based phylogenetic tree (Fig. 2) and a voucher
specimen No. 02 was deposited in the herbarium of ChalapathiFigure 1 Twig of Pergularia daemia bearing ﬂowers and fruit.
The leaves are almost glabrous above and velvety below. The
ﬂower corolla forms a greenish-yellow or dull white tube. The
fruits release ovate seeds covered with velvety hairs.Institute of Pharmaceutical Sciences, Lam, Guntur, India
(Fig. 1).
2.2. Extraction, isolation and analysis by GC–MS
As the plant was selected based on the traditional use, the ini-
tial extract was prepared as described by the traditional healer.
10 gms of the leaf powder was extracted using 200 MilliQ-
water at 50 C for 4h and cooled to room temperature, ﬁltered
and treated with methylene chloride (3  100 ml) to extract
more lipophilic components. The Leaf residue (remained on
ﬁlter paper) was dissolved in 200 mL of n-Hexane and soni-
cated for 30 min to dissolve any lipophilic substance that is
not removed from the leaf powder [21,22]. Methylene chloride
and n-Hexane extracts are combined and passed through a
sodium sulphate plug. The combined extract was concentrated
in a rotary evaporator up to 10 mL and then further upto 1 mL
using nitrogen concentrator and was analysed using GC–MS
(5975C Inert MSD) system equipped with a splitless capillary
injection port using HP-5MS, 0.25 mm  0.25 lm  30 m col-
umn [23]. Helium (99.999%) was used as a carrier gas at a con-
stant ﬂow of 1 mL/min and an injection volume of 0.5 EI was
employed with an injector volume of 1 lL under splitless
mode. Ion source temperature was maintained at 280 C.
The oven temperature was programed from an initial temper-
ature of 70 C hold for 5.0 min with an increase of 10 C/min
to 320 C for a total run time of 40 min. Mass spectra were
taken at 70 eV, a scan interval of 0.5 s and with MS scan mode
from 25 to 550 m/z. The chromatograms thus obtained were
recorded (Fig. 4).
2.3. In-vitro tests for the inhibition of PLA2 activity
PLA2 activity of N. naja venom was performed using an indi-
rect haemolytic assay on agarose–erythrocyte–egg yolk gel
plates [24]. Increasing doses of the venom were added to the
wells in the agarose gels with 1.2% sheep erythrocytes, 1.2%
egg yolk as a source lecithin and 10 mM CaCl2, incubated at
37 C overnight and haemolytic haloes were measured
(Fig. 3). Control wells contain 15 lL of saline. The minimum
indirect haemolytic dose (MIHD) corresponds to the dose that
induced a haemolytic halo of 20 mm diameter. 1 MIHD of
N. naja venom was used. Test solutions and dose of venom
(0.005 mL each) were pre-incubated for 1hour at 37 C. After
centrifugation at 10,000 rpm for 10 min, the supernatant
(20 lL) was tested for PLA2 activity by incubating the plates
at 37 C for 20 h. Results were expressed as percentage inhibi-
tion of enzymatic activity (Table 1 and Fig. 7), where 100%
inhibition produced no clear zone. The total phenol and ﬂavo-
noid content of the extract was estimated using tannic acid and
quercetin standard graphs (Figs. 5 and 6).
2.4. In vitro tests for the inhibition of protease activity of the
venom
Venom Proteolytic activity was assayed as described by
Ibrahim et al. [25] with a slight modiﬁcation. 1 mL of N. naja
(10–2500 lg) with 1 mL of 1% casein in 0.1 M Sorensen’s
phosphate buffer of pH 7.6 was incubated for 30 min at
37 C. Undigested casein was precipitated and the reaction
was terminated by adding 3 ml of 5% trichloroacetic acid
Figure 2 By using the Pergularia daemia trnL-trnF intergenic spacer, partial sequence; plastid a phylogenetic tree was constructed.
Maximum likelihood phylogram was discovered in 8 independent ratchet analyses. Note the broken branch to the outgroup, Cynanchum,
with the exception of a few weakly supported nodes, this topology is identical to the strict consensus of most parsimonious trees
discovered.
Figure 3 In-vitro PLA2 activity of the extract in agarose gel
impregnated with 1.2% sheep erythrocytes and 1.2% egg yolk and
10 mM CaCl2. 1–8 Cavities show inhibition of haemolytic activity
of naja venom by increasing dose of plant extract (5, 10, 15, 20, 25,
30, 35, 40 ll of plant extract) in series.
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supernatant was measured at 366 nm. The activity of protease
was deﬁned as the amount of enzyme that hydrolyses 1 lmol
of amino acids (in terms of tyrosine) from casein per minute
under the standard assay conditions. P. daemia extract was
evaluated for its anti-proteolytic potential against the venom
by incubating each 0.5 mL of the test solution (100, 250, 500,
1000 lg w/v) with 200 lL of venom for 1 h at 37 C. Blanks
containing only the buffer and extract were run in parallel.
The optical density was measured at 366 nm (Table 2 and
Fig. 8).
2.5. Inhibition of hyaluronidase activity
Inhibition of hyaluronidase enzyme activity was determined
turbidometrically [26]. NN venom (25–1000 lg) in phosphate
buffer saline (PBS) of pH 7.4 was incubated with 50 lg of hya-
luronic acid in 1 mL 0.2 M sodium acetate buffer (pH 5) with
0.15 M sodium chloride for 25 min at 37 C. The reaction was
Figure 4 GC–MS chromatogram of P. daemia leaf extract showing b-sitosterol, a-amyrin, b-amyrin and lupeol Chromatogram b, c, d, e
shows compounds identiﬁed compared to inbuilt NIST library.
214 S.T.V. Raghavamma et al.stopped by adding 2 mL of 2.5% cetyl-trimethyl-ammonium
bromide in 2% sodium hydroxide. Optical density was read
at 400 nm after 30 min against blank. Turbidity-reducing
activity was expressed as a percentage of the remaining hya-
luronic acid, taking the absorbance of the blank as 100%.
The venom concentration that produced a reduction in turbid-
ity of 50% was used in inhibition experiments. The percent-
age inhibition of venom hyaluronidase activity by the extracts
was determined after pre-incubating an equal volume (100 lL)
of each test sample in acetate buffer with NN venom in PBS
[0.01–100 lg] for 30 min at 37 C, then hyaluronidase activity
was measured. Blanks were run in parallel (Table3 and Fig. 9).
2.6. Molecular docking studies
The potential binding site of the target protein and lead candi-
dates are identiﬁed by a molecular docking algorithm Mol
Dock, based on a novel search algorithm that combines differ-
ential evolution techniques with a cavity prediction algorithm.
Genetic algorithm, Mol Dock SE with default parameters such
as 1500 iterations, population size 50, with maximum 300
steps was used. The scoring scheme was derived from PLP(Piecewise Linear Potential) scoring functions [27]. The com-
pounds used for docking are drawn as 2-D structures using
ISIS Draw software and converted to 3-dimensional Mol2 ﬁles
using ProDRG2 server [28]. We tested three different scoring
functions such as GOLD score, M E Dock server and Mol
Dock score of Molegro software were tested. The X-ray crystal
structures of Phospholipase A2, 1A3D, L-amino acid oxidase
and 4E0V were downloaded from PDB database [29–32].
Ligand cavities were detected in all enzymes and by default
the major cavity was selected for analysis before docking
(Tables 4 and 5 and Figs. 10 and 11).
3. Results and discussion
The resulting GC–MS chromatograms are compared with the
standard and were found to contain b sitosterol, a-amyrin,
b-amyrin and lupeol. About 5 lg of the N. naja venom pro-
duced 20 mm diameter haemolytic haloes that are considered
to be 1 U (U/5 lg) in agarose sheep erythrocyte gel. This
conﬁrms the PLA2 activity of naja venom. P. daemia extract
was capable of inhibiting PLA2 dependent haemolysis in a
dose dependent manner. 40 lL of plant extract corresponding
Table 1 Percentage inhibition of PLA2 activity of venom by
plant extract using an indirect haemolytic assay on agarose–
erythrocyte–egg yolk gel plates method and corresponding
phenol content.
S. no Extract
(ll)
Concentration of phenols
(lg)
Inhibition
(%)
1 5 2.5 50
2 10 5.0 50
3 15 7.5 55
4 20 10.0 61
5 25 12.5 61
6 30 15.0 66.6
7 35 17.5 72.2
8 40 20.0 83.3
Figure 5 Tannic acid standard graph for the estimation of
phenols from Pergularia daemia extract using the Folins method.
Figure 6 Standard graph of quercetin for the estimation of
ﬂavonoids from Pergularia daemia extract.
Figure 7 Graph shows percentage inhibition of PLA2 activity
corresponding to phenolic content of the extract.
Table 2 Venom (200 lL) protease inhibition activity in of
Pergularia daemia in terms of percentage.
S.
no
Extract
ll
Concentration of
phenols (lg)
O.D
366 nm
Inhibition
(%)
1 100 0.66 –
2 250 125 0.088 72
3 500 250 0.139 55.8
4 1000 500 0.191 39.3
Figure 8 Venom protease inhibition activity of Pergularia
daemia plotted against the corresponding concentration of the
phenolic component in the extract.
Table 3 Percentage inhibition of venom hyaluronidase activ-
ity of Pergularia daemia extract and its corresponding phenol
content.
S. no Concentration of phenols (lg) Inhibition (%)
1 0.01 8
2 0.1 20
3 1 45
4 10 70
5 100 75
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sheep RBC’s induced by naja venom. The ED50 of P. daemia
was found to be 5 lL corresponding to 2.5 lg of the phenolic
content. 250 lL of the extract shows 72% of activity. The inhi-
bition of protease activity at low concentration conﬁrms the
basic role of triterpenes and sterols identiﬁed in the extract.
Snake venom Phospholipase A2 with PDB code 1A3D
extracted from Protein Data Bank was devoid of co-
crystallized ligand. Two cavities were detected using cavity
detection algorithm in Molegro Virtual Docker by comparing
the cavity formed by co-crystallized bound ligand of 4DBK.
Nearly 50% of residues in both the cases are identical.Moreover, the volume of each cavity was 100.352 (1A3D)
and 197.12 A˚ (4DBK) respectively. Binding afﬁnities
and probable mode of interactions of four ligands, viz.
Figure 9 Percentage inhibition of hyaluronidase activity of
Pergularia daemia plotted against corresponding concentration of
phenolic component in the extract.
Figure 10 Energy contributions of active site amino acids of
1A3D with b-sitosterol. Atoms contributing energy are repre-
sented as spheres (size corresponds to the energy associated).
Figure 11 Energy contributions of active site amino acids of
4E0V with b-sitosterol. Atoms contributing energy are represented
as spheres (size corresponds to the energy associated).
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residues of 1A3D resulted in dock scores between
92.18 kcal/mol and 125.94 kcal/mol respectively (Table 4).
b-sitosterol displayed high afﬁnity (125.94 kcal/mol). How-
ever, this ligand and lupeol are without H-bond interactions.
Hydrophobic and steric interactions might exist. On the other
hand, ligand efﬁciency (moldock score divided by heavy
atoms) resulted in 4.198 kcal/mol of ligand efﬁciency for
b-sitosterol that was much better than the remaining ligands.
The energy contributions of active site residues with ligand
molecule, b-sitosterol, are predominantly from Cys, Gly,
Phe, and Tyr amino acids.
L-Amino acid oxidase, 4E0V selected as receptor model has
a co-crystallized ligand, FAD with one cavity. Hence ligand
docking was initiated by choosing the cavity as active site.
The resultant dock scores (Table 5) suggest the fact that almost
all ligands present similar competitive inhibition (around
133 kcal/mol) at the active site except b-sitosterol
(157.521 kcal/mol). This high afﬁnity of b-sitosterol might
be attributed to the ligand efﬁciency (5.2507 kcal/mol) as
well as hydrogen bond interactions with Arg90 and Tyr372
respectively. The energy contributions of active site residues
with ligand molecule, b-sitosterol, were predominantly from
Gly, Thr and Tyr amino acids.
An attempt has been made to isolate a few compounds
from P. daemia that are expected to have inhibitory potential
against snake venom phospholipase A2 and L-amino acid oxi-
dase. The work complies with the literature, which states that
most of the phenolic acids, terpenoids, and ﬂavonoids from the
plant extract are responsible for snake venom neutralizing abil-
ity [33]. There exists a strong correlation between total phe-
nols, ﬂavonoids and their biological activities. Of the four
compounds, b-sitosterol, b-amyrin, a-amyrin and lupeol that
were identiﬁed by GC–MS, it was observed from molecular
docking studies that b-sitosterol has high afﬁnity of binding
to the active site regions of alpha cobra toxin, phospholipase
A2 and L-amino acid oxidase. Computational analysis revealedTable 4 Dock scores of four ligands against 1A3D with H-bond in
Ligands Mol Wt Mol Dock score (kcal/mol) H-bond
a-Amyrin 426.717 92.1781 O-Tyr 2
b-Amyrin 425.709 96.8369 O-Tyr 2
b-Sitosterol 414.707 125.939 –
Lupeol 426.717 93.8994 –the strength of binding and important amino acids that confer
the stability of b-sitosterol within the active site regions of
these enzymes. It is the abundant phyto-steroid isolated from
various plant sources which are identiﬁed for their anti-snake
venom activity like Aristolochia serpentaria (the Virginia snake
root) [34], Cissampelos glaberrima (snake liana in Brazil) [35]
Marsypianthes chamaedrys (snake plant) [36] and Ophiorrhiza
mungos (Ophiorrhiza is snake root in Latin) [37].teracting residues and ligand efﬁciency (LE).
ing amino acids Heavy atoms Ligand eﬃciency (kcal/mol)
7, Gly 29 31 2.9735
7, Gly 29 31 3.1238
30 4.1979
31 3.029
Table 5 Dock scores of four ligands against 4E0V with H-bond interacting residues and ligand efﬁciency (LE).
Ligands Mol Wt Mol Dock score (kcal/mol) H-bonding amino acids Heavy atoms Ligand eﬃciency (kcal/mol)
a-Amyrin 426.717 133.106 O Met 43 31 4.2937
b-Amyrin 425.709 143.833 O Met 43, N Ser 44 31 4.6398
b-Sitosterol 414.707 157.521 N Arg 90, O Tyr 372 30 5.2507
Lupeol 426.717 131.528 O Met 43 31 4.2428
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Hence, it can be concluded that b-sitosterol isolated from
P. daemia is responsible for anti-snake venom potential of
the extract, provided, further experimental investigations on
this active principle would highlight the importance of this
compound.
The main groups of triterpenoids are represented by tetra
cyclic and pentacyclic derivatives. Pentacyclic triterpenoids
are all based on a 30-carbon skeleton comprising ﬁve, six-
member rings (ursanes and lanostanes) or four six-member
rings and one ﬁve-member ring (lupanes and hopanes) [38].
Pentacyclic triterpenoids a-amyrin, betulinic acid and betuli-
naldehyde, and other related triterpenes such as oleanolic acid
(oleanic acid), ursolic acid, zeylasteral were reported to possess
anti-snake venom activity [39]. But Lupeol, a-amyrin and
b-amyrin belonging to this group isolated from P. daemia
showed less effectiveness on Naja venom. Hence the synergistic
activity of all the compounds in the extract might potentiate
the anti-venom activity of the plant in its folk use.
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